Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.38 |
| ▸ | ARG2 | P78540 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465303 | 0.94 | HSD17B10 (0.44) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL5052375 | 0.92 | HSD17B10 (0.50) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL7837862 | 0.92 | CYP1A2 (0.54) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL18158087 | 0.89 | CYP1A2 (0.52) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL3427325 | 0.89 | HSD17B10 (0.41) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL5052250 | 0.89 | SMN1; SMN2 (0.43) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL11713997 | 0.89 | HSD17B10 (0.41) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL3920017 | 0.89 | CYP1A2 (0.52) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL13488737 | 0.89 | CYP1A2 (0.52) | CYP1A2HSD17B10CYP2C9HPGDMAPK1 | |
| SCHEMBL19206141 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101045759-B | Styrene or substituted styrene polymer type quaternary ammonium salt antistat or bacterial agent and preparation method thereof | DINGLAN GREEN CHEMICAL INST CO LTD CHANGZHOU | 2011-06-01 | — | — | CN | claimed |
| EP-1463506-B1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2009-10-21 | — | — | EP | claimed |
| US-7402585-B2 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2008-07-22 | — | — | US | claimed |
| CN-101045759-A | Styrene or substituted styrene polymer type quaternary ammonium salt antistat or bacterial agent and preparation method thereof | DINGLAN GREEN CHEMICAL INST CO (CN) | 2007-10-03 | — | — | CN | claimed |
| EP-2784059-B1 | Method for isolating tertiary amino alcohol | TOSHIBA KK (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-9181174-B2 | Method for isolating tertiary amino alcohol | KABUSHIKI KAISHA TOSHIBA (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20140296576-A1 | METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL | KABUSHIKI KAISHA TOSHIBA (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2784059-A1 | Method for isolating tertiary amino alcohol | Kabushiki Kaisha Toshiba (JP) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013143466-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVE AS AURORA KINASE INHIBITOR | 广东东阳光药业有限公司 (CN) | 2013-10-03 | — | — | WO | disclosed |
| CN-101045759-B | Styrene or substituted styrene polymer type quaternary ammonium salt antistat or bacterial agent and preparation method thereof | DINGLAN GREEN CHEMICAL INST CO LTD CHANGZHOU | 2011-06-01 | — | — | CN | disclosed |
| US-7862807-B2 | Dendrimers as molecular translocators | UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) | 2011-01-04 | — | — | US | disclosed |
| US-7691867-B2 | Chemical compounds | ASTRAZENECA AB (SE) | 2010-04-06 | — | — | US | disclosed |
| EP-1545462-A2 | DENDRIMERS AS MOLECULAR TRANSLOCATORS | The Regents of the University of California (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20050070561-A1 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2005-03-31 | — | — | US | disclosed |
| WO-2004113324-A1 | CHINAZOLINE DERIVATIVES AS AURORA KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2004-12-29 | — | — | WO | disclosed |
| WO-2004094410-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2004-11-04 | — | — | WO | disclosed |
| EP-1463506-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | Astrazeneca AB (SE) | 2004-10-06 | — | — | EP | disclosed |
| WO-2004009665-A2 | DENDRIMERS AS MOLECULAR TRANSLOCATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2004009666-A2 | DENDRIMERS AS MOLECULAR TRANSLOCATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003055491-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296576-A1 | METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL | ADH1C, AADAT, ADH1A | CYP1A2 1631/4885HSD17B10 1563/4885CYP2C9 2513/4885 |
| US-20050070561-A1 | Substituted quinazoline derivatives as inhibitors of aurora kinases | AURKC, AURKA, AURKB | CYP1A2 2009/4885HSD17B10 3215/4885CYP2C9 3423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.